Expert Interviews

Evolving Diabetes Care: Strategic Adjustments and Combination Therapy Benefits for Older Adults
August 12, 2024

Diabetes specialists examine the shifting paradigm of type 2 diabetes treatment, highlighting the role of combination therapies and emerging approaches specifically designed for geriatric patients.

Tailoring Insulin Therapy: Key Considerations for Dosing and Glucose Control
August 12, 2024

The panel examines crucial factors in determining appropriate medication dosages and managing glucose levels for elderly patients with type 2 diabetes.

Patient Case 2: Exploring the Advantages of Combination Therapy in T2D and Addressing Affordability and Access Issues
August 12, 2024

Medical experts analyze a case involving a 78-year-old man with a 15-year history of Type 2 Diabetes Mellitus.

Patient Case 1: Managing Geriatric Syndrome Through Targeted Glycemic Goals
August 12, 2024

A panel of medical experts presents a case study featuring a 68-year-old woman exhibiting classic diabetes symptoms—polyuria, polydipsia, and significant weight loss—along with a notably elevated glucose level of 458 mg/dL.

Understanding Aging: Tailoring Care for Older Adults in Diverse Settings
August 12, 2024

Medical doctors examine strategies for customizing diabetes care for older adults across various environments, from home settings to healthcare facilities.

Geriatric Diabetes Care: Optimizing Type 2 Diabetes Management Insights from Dr. John Anderson
August 12, 2024

Medical experts explore personalized diabetes management strategies, emphasizing the critical need to tailor treatments for older adults.

Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab
August 02, 2024

The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.

Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process
August 02, 2024

Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.

Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
August 02, 2024

Diabetes specialists outline the patient selection protocol for teplizumab and describe the teplizumab infusion process.

Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
August 02, 2024

Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.